You are here

Helsinn Healthcare SA

Member Since 2014

Riccardo Braglia, MBA

Helsinn Group Vice Chairman & Group Chief Executive Officer

Riccardo Braglia is Helsinn Group's Vice Chairman and CEO, Managing Director and Member of Helsinn Holding's Board of Directors, Switzerland and Executive Committee for Helsinn Group's strategic management. He is the Board Member of Helsinn Healthcare, Switzerland as well as of Helsinn Advanced Synthesis, Switzerland. Mr. Braglia is also Member of Helsinn Birex Pharmaceuticals’ Board of Directors, Ireland and Chairman of Helsinn Therapeutics’ Board of Directors, USA.

He is PDG (Président Directeur Général) – Gérant Associé of Helsinn International Services à Montecarlo.

Riccardo Braglia is also a Board Member of Thorne Research, Greenwich CT/USA and Health as well as Member of Management Committee of the American Chamber of Commerce.

Riccardo Braglia is an entrepreneur; he won the “2011 Best Entrepreneur of the Year in Italian-speaking Switzerland Award” awarded by Swiss Venture Club as well the “Ernst & Young Award for the best Swiss Entrepreneur of the Year 2012 in the High Tech/Life Sciences category”. He represented Switzerland at the “Ernst & Young World Entrepreneur of the Year 2013 Award”.

Riccardo Braglia holds a degree in Business Economics with specialization in Industrial Management from Luigi Bocconi University, Milan.

CEO Cancer Gold Standard™

Gold Standard  Employer

Gold Standard Employer Since 2015 | Global Gold Standard Employer Since 2015


Helsinn's mission is to bring respect, integrity, and quality to our products, services and all that we do to improve health and quality of life in every person affected by cancer. We are honored to be accredited CEO Cancer Gold Standard which means quality of life for our employees and is an additional step forward to reach our mission.

— Riccardo Braglia, MBA

Gold Standard  Task Force Participation

Task Force Member(s): Linda Burns, Executive Director, Human Resources

Life Sciences Consortium

LSC  Task Force Participation

Task Force Member(s): Sergio Cantoreggi, PhD, Chief Scientific Officer & Global Head of R&D

Further Support

The CEO Cancer Gold Standard was featured at Helsinn's 40th Anniversary Celebration during the JP Morgan annual conference, Janurary 2016

Founding Member, CEO Roundtable on Cancer - China

Helsinn Healthcare SA

The Helsinn Group is one of the world’s leading supportive cancer care companies. Our business model is built on forging lasting alliances with worldwide partners who share our vision. Through a mix of integrated early and late stage licensing programs and our own development, we have developed a comprehensive portfolio of effective pharmaceuticals and specialist therapies that are sold in over 90 countries, and a late stage pipeline of future cancer therapies which will meet unmet medical needs in the treatment of cancer.